Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Final Approval for Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation)".